Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT07340476
What this trial is testing

Evaluate the PK Similarity of AK112 in Healthy Chinese Male Subjects

Who this might be right for
Healthy Male Subjects
Akeso 108
Early research (Phase 1)Study completedNCT04695847
What this trial is testing

M1231 in Participants With Solid Tumors

Who this might be right for
Metastatic Solid TumorsEsophageal CancerNon-Small Cell Lung Cancer
EMD Serono Research & Development Institute, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT04590326
What this trial is testing

Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
Regeneron Pharmaceuticals 612
Early research (Phase 1)Study completedNCT05216835
What this trial is testing

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Classical Hodgkin Lymphoma
AstraZeneca 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05092347
What this trial is testing

Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)

Who this might be right for
Chronic Kidney Disease (CKD)
Regeneron Pharmaceuticals 43
Early research (Phase 1)Study completedNCT03761017
What this trial is testing

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Who this might be right for
Squamous Cell Non Small Cell Lung CancerProstate Cancer MetastaticCutaneous Melanoma+3 more
MacroGenics 162
Early research (Phase 1)Looking for participantsNCT06259552
What this trial is testing

SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors

Who this might be right for
Solid TumorHNSCCRCC+1 more
SparX Biotech(Jiangsu) Co., Ltd. 232
Early research (Phase 1)Looking for participantsNCT06929663
What this trial is testing

AK146D1 for Injection in the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Akeso 48
Early research (Phase 1)Looking for participantsNCT07528352
What this trial is testing

External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
University of Utah 12
Testing effectiveness (Phase 2)Looking for participantsNCT06892548
What this trial is testing

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Who this might be right for
Advanced Lung Cancer
BioNTech SE 594
Early research (Phase 1)Looking for participantsNCT07753226
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Who this might be right for
Breast CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 39
Early research (Phase 1)Looking for participantsNCT07067567
What this trial is testing

AK146D1 for Injection in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Akeso 200
Testing effectiveness (Phase 2)Looking for participantsNCT06669247
What this trial is testing

Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals 186
Early research (Phase 1)Ended earlyNCT05369000
What this trial is testing

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Lava Therapeutics 96
Early research (Phase 1)Looking for participantsNCT06835140
What this trial is testing

CD123-CD16-NK Cells Immunotherapy for AML

Who this might be right for
AML (Acute Myelogenous Leukemia)NK CellCD123+ Acute Myeloid Leukemia
Chunji Gao 9
Testing effectiveness (Phase 2)Looking for participantsNCT03564340
What this trial is testing

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Who this might be right for
Recurrent Ovarian CancerRecurrent Fallopian Tube CancerRecurrent Primary Peritoneal Cancer+3 more
Regeneron Pharmaceuticals 890
Early research (Phase 1)Study completedNCT05577182
What this trial is testing

Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies

Who this might be right for
Advanced Malignancies
Incyte Corporation 46
Early research (Phase 1)Study completedNCT02892123
What this trial is testing

Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers

Who this might be right for
HER2-expressing Cancers
Jazz Pharmaceuticals 279
Testing effectiveness (Phase 2)Active Not RecruitingNCT05410418
What this trial is testing

Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma

Who this might be right for
Lymphoma, FollicularFollicular Lymphoma
Washington University School of Medicine 34
Testing effectiveness (Phase 2)Ended earlyNCT05159388
What this trial is testing

PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Servier Bio-Innovation LLC 46
Next Page